HAMPTON, N.J. (AP) — HAMPTON, N.J. (AP) — Celldex Therapeutics Inc. (CLDX) on Thursday reported a loss of $78.7 million in its first quarter.
On a per-share basis, the Hampton, New Jersey-based company said it had a loss of $1.18.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.
The biopharmaceutical company posted revenue of $15,000 in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $1.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CLDX at https://www.zacks.com/ap/CLDX